Related references
Note: Only part of the references are listed.The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia
Xavier Leleu et al.
BLOOD (2007)
Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma
Yazan Alsayed et al.
BLOOD (2007)
Emerging drugs in multiple myeloma
Irene M. Ghobrial et al.
EXPERT OPINION ON EMERGING DRUGS (2007)
Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes
M Parmo-Cabanas et al.
JOURNAL OF PATHOLOGY (2006)
The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone
N Flomenberg et al.
BLOOD (2005)
Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: Pivotal role of the SDF-1-CXCR4 axis
M Kucia et al.
STEM CELLS (2005)
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment
DA Sipkins et al.
NATURE (2005)
Clinical use of AMD3100 to mobilize CD34+ cells in patients affected by non-Hodgkin's lymphoma or multiple myeloma
G Grignani et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Molecular characterization of PS-341 (bortezomib) resistance:: implications for overcoming resistance using lysophosphatidic acid acyltransferase (LPAAT)-β inhibitors
T Hideshima et al.
ONCOGENE (2005)
Stem cell transplantation in multiple myeloma (0, 1, or 2)
JL Harousseau
CURRENT OPINION IN ONCOLOGY (2005)
Integrin α4β1 involvement in stromal cell-derived factor-1α-promoted myeloma cell transendothelial migration and adhesion:: role of cAMP and the actin cytoskeleton in adhesion
M Parmo-Cabañas et al.
EXPERIMENTAL CELL RESEARCH (2004)
Rapid mobilization of CD34+cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma
SM Devine et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors
CS Mitsiades et al.
CANCER CELL (2004)
Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination
S López-Giral et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Advances in biology of multiple myeloma: clinical applications
T Hideshima et al.
BLOOD (2004)
In vivo flow cytometer for real-time detection and quantification of circulating cells
J Novak et al.
OPTICS LETTERS (2004)
A review of the proteasome inhibitor bortezomib in multiple myeloma
PG Richardson
EXPERT OPINION ON PHARMACOTHERAPY (2004)
Drug therapy: Multiple myeloma
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A phase 2 study of bortezomib in relapsed, refractory myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341
T Hideshima et al.
BLOOD (2003)
Cutting edge: Profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues
T Nakayama et al.
JOURNAL OF IMMUNOLOGY (2003)
Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu
T Hideshima et al.
BLOOD (2003)
Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors
R Sotillo et al.
EMBO JOURNAL (2001)
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications
D Gupta et al.
LEUKEMIA (2001)
Biologic sequelae of interleukin-6 induced P13-K/Akt signaling in multiple myeloma
T Hideshima et al.
ONCOGENE (2001)
Induction of apoptosis in human T cells by Actinobacillus actinomycetemcomitans cytolethal distending toxin is a consequence of G2 arrest of the cell cycle
BJ Shenker et al.
JOURNAL OF IMMUNOLOGY (2001)
Chemokine stromal cell-derived factor-1α modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1
F Sanz-Rodríguez et al.
BLOOD (2001)
Share Paper
